rejection
-
Novartis Receives Approval for Organ Rejection Prevention Drug
The US Food and Drug Administration (FDA) has approved Zortress (everolimus) oral tablets for the prevention of organ rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. The drug is to be given in combination with r…
rejection | 27 May 2010
